How Does InnovAge Company Actually Work?

InnovAge company sells a subscription-style care model: the InnovAge PACE program bundles primary care, specialty visits, medication management, adult day health, home-based care, behavioral health, hospice/palliative transitions, and non – emergency transportation into a single benefit package. The model replaces fragmented fee-for-service encounters with comprehensive care coordination.

InnovAge serves seniors who are certified as needing nursing – home level care but prefer to remain in the community, plus their informal caregivers and family decision – makers. Participants typically enroll through referrals, assessments, or by contacting InnovAge enrollment (see InnovAge enrollment process and InnovAge enrollment eligibility requirements).

InnovAge healthcare model emphasizes care coordination to cut preventable hospitalizations; internal data and third – party analyses report a 44 percent reduction in preventable hospitalizations versus traditional nursing – home residents. That translates to fewer acute episodes, lower total cost of care, and better functional outcomes for members.

Families choose InnovAge services because the model centralizes care coordination, offers on – site and home – based options (including telehealth and virtual visit services), and covers prescriptions and transportation, reducing logistical burden. The integrated approach is hard to replace when avoiding institutionalization and managing complex chronic needs; see Where InnovAge Company Is Going for context.

The InnovAge PACE program is paid mostly via capitated monthly fees from Medicare and Medicaid; this single revenue stream underpins the InnovAge healthcare model because it aligns incentives to prevent costly hospital care.

Secondary revenue comes from supplementary services and coordination fees, limited pharmacy reimbursements, and occasional private-pay services tied to InnovAge services and care coordination process for caregivers.

InnovAge is paid per enrolled member per month (PMPM) under subscription-like capitation contracts; state and federal capitation rate adjustments raise average PMPM over time.

Revenue growth depends on member months and capitation rate hikes; InnovAge projects 92,900-95,700 member months for 2026 and FY2026 revenue of 925-950 million dollars.

InnovAge PACE program leverages scale as the nation's largest PACE provider to deliver home-based primary care and long-term services. States save roughly 6,000 dollars per enrolled Medicaid beneficiary annually, which underpins referrals and public payor support.

Integrated teams coordinate medical, behavioral, and social support across day centers and home visits, reducing hospitalizations and readmissions. Care coordination and medication management drive measurable utilization reductions in InnovAge services.

The model depends on stable Medicare and Medicaid reimbursements; the V28 Medicare Advantage payment model transition on January 1, 2026, alters risk score calculation and introduces reimbursement volatility that could materially affect margins.

Chronic shortages in nursing and direct care staff limit capacity growth and raise labor costs, threatening service quality and enrollment throughput in InnovAge enrollment process and home-based care options.

InnovAge reported net income of 11.8 million dollars in Q2 2026 and an Adjusted EBITDA margin of 9.2 percent. Management projects fiscal 2026 Adjusted EBITDA of 70 million to 75 million dollars, but those targets hinge on successful risk-score adaptation and labor cost control.

Monitor CMS guidance on V28 implementation, InnovAge disclosures on risk score modeling, enrollment trends in InnovAge PACE program, and turnover rates for nursing/direct care. See deeper background in History of InnovAge Company Explained.